FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004602458> ?p ?o ?g. }

• W2004602458 endingPage "1954" @default.
• W2004602458 startingPage "1949" @default.
• W2004602458 abstract "APOE-epsilon4 increases the risk of cognitive decline, while elderly women who take estrogen may have less risk of cognitive decline. The authors sought to determine whether estrogen use modifies the association between APOE-epsilon4 and cognitive decline.- As part of the Cardiovascular Health Study, 3,393 Medicare-eligible women (> or =65 years) were randomly selected and recruited from Sacramento County, CA; Washington County, MD; Forsyth County, NC; and Pittsburgh, PA. Cognitive testing was administered annually; the authors studied the 2,716 women with cognitive testing on > or =2 visits. They analyzed change in score on the Modified Mini-Mental State Examination (3MS) as a function of estrogen use, APOE genotype, and baseline common and internal carotid artery wall thickening.A total of 297 (11%) women were current estrogen users and 336 (12%) were past estrogen users. Over the 6-year average follow-up, baseline current users declined 1.5 points on the 3MS whereas never users declined 2.7 points (p = 0.023). Compared with epsilon4-negative women, epsilon4-positive women had a greater adjusted hazard ratio of cognitive impairment (3MS < 80), hazard risk [HR] = 1.47; 95% CI, 1.13 to 1.90. There was an interaction between estrogen use and epsilon4 presence (p = 0.037). Among epsilon4-negative women, current estrogen use reduced the risk of adjusted cognitive impairment compared with never users by almost half (HR = 0.59; 95% CI, 0.36 to 0.99), whereas, it did not reduce the risk among epsilon4-positive women (current use, HR = 1.33; 95% CI, 0.74 to 2.42). Compared with never use, current estrogen use was associated with less internal and common carotid wall thickening in epsilon4-negative women but not in epsilon4-positive women (p for interaction < 0.05 for both). Differences remained after adjusting for age, education, race, and stroke.Estrogen use was associated with less cognitive decline among epsilon4-negative women but not epsilon4-positive women. Potential mechanisms, including carotid atherosclerosis, by which epsilon4 may interact with estrogen and cognition warrant further investigation." @default.
• W2004602458 created "2016-06-24" @default.
• W2004602458 creator A5026563364 @default.
• W2004602458 creator A5037758542 @default.
• W2004602458 creator A5038974466 @default.
• W2004602458 creator A5057137573 @default.
• W2004602458 creator A5087916636 @default.
• W2004602458 date "2000-05-23" @default.
• W2004602458 modified "2023-10-10" @default.
• W2004602458 title "Estrogen use, APOE, and cognitive decline" @default.
• W2004602458 cites W1947395210 @default.
• W2004602458 cites W1963783263 @default.
• W2004602458 cites W1965834391 @default.
• W2004602458 cites W1966593898 @default.
• W2004602458 cites W1972598797 @default.
• W2004602458 cites W1977374270 @default.
• W2004602458 cites W1979282325 @default.
• W2004602458 cites W1984737558 @default.
• W2004602458 cites W1991516886 @default.
• W2004602458 cites W2000548634 @default.
• W2004602458 cites W2005520585 @default.
• W2004602458 cites W2011716448 @default.
• W2004602458 cites W2012042221 @default.
• W2004602458 cites W2023072905 @default.
• W2004602458 cites W2026267640 @default.
• W2004602458 cites W2057124817 @default.
• W2004602458 cites W2058272273 @default.
• W2004602458 cites W2070731787 @default.
• W2004602458 cites W2098533587 @default.
• W2004602458 cites W2102493638 @default.
• W2004602458 cites W2106067304 @default.
• W2004602458 cites W2109137609 @default.
• W2004602458 cites W2111649142 @default.
• W2004602458 cites W2111774300 @default.
• W2004602458 cites W2130076239 @default.
• W2004602458 cites W2161197885 @default.
• W2004602458 cites W2170128453 @default.
• W2004602458 cites W4233622592 @default.
• W2004602458 cites W4253546703 @default.
• W2004602458 doi "https://doi.org/10.1212/wnl.54.10.1949" @default.
• W2004602458 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10822435" @default.
• W2004602458 hasPublicationYear "2000" @default.
• W2004602458 type Work @default.
• W2004602458 sameAs 2004602458 @default.
• W2004602458 citedByCount "307" @default.
• W2004602458 countsByYear W20046024582012 @default.
• W2004602458 countsByYear W20046024582013 @default.
• W2004602458 countsByYear W20046024582014 @default.
• W2004602458 countsByYear W20046024582015 @default.
• W2004602458 countsByYear W20046024582016 @default.
• W2004602458 countsByYear W20046024582017 @default.
• W2004602458 countsByYear W20046024582018 @default.
• W2004602458 countsByYear W20046024582019 @default.
• W2004602458 countsByYear W20046024582020 @default.
• W2004602458 countsByYear W20046024582021 @default.
• W2004602458 countsByYear W20046024582022 @default.
• W2004602458 countsByYear W20046024582023 @default.
• W2004602458 crossrefType "journal-article" @default.
• W2004602458 hasAuthorship W2004602458A5026563364 @default.
• W2004602458 hasAuthorship W2004602458A5037758542 @default.
• W2004602458 hasAuthorship W2004602458A5038974466 @default.
• W2004602458 hasAuthorship W2004602458A5057137573 @default.
• W2004602458 hasAuthorship W2004602458A5087916636 @default.
• W2004602458 hasConcept C118552586 @default.
• W2004602458 hasConcept C126322002 @default.
• W2004602458 hasConcept C144024400 @default.
• W2004602458 hasConcept C149923435 @default.
• W2004602458 hasConcept C15744967 @default.
• W2004602458 hasConcept C169900460 @default.
• W2004602458 hasConcept C207103383 @default.
• W2004602458 hasConcept C23131810 @default.
• W2004602458 hasConcept C2777164284 @default.
• W2004602458 hasConcept C2779134260 @default.
• W2004602458 hasConcept C2779483572 @default.
• W2004602458 hasConcept C2780733421 @default.
• W2004602458 hasConcept C29456083 @default.
• W2004602458 hasConcept C2984863031 @default.
• W2004602458 hasConcept C44249647 @default.
• W2004602458 hasConcept C57089818 @default.
• W2004602458 hasConcept C71924100 @default.
• W2004602458 hasConcept C74909509 @default.
• W2004602458 hasConceptScore W2004602458C118552586 @default.
• W2004602458 hasConceptScore W2004602458C126322002 @default.
• W2004602458 hasConceptScore W2004602458C144024400 @default.
• W2004602458 hasConceptScore W2004602458C149923435 @default.
• W2004602458 hasConceptScore W2004602458C15744967 @default.
• W2004602458 hasConceptScore W2004602458C169900460 @default.
• W2004602458 hasConceptScore W2004602458C207103383 @default.
• W2004602458 hasConceptScore W2004602458C23131810 @default.
• W2004602458 hasConceptScore W2004602458C2777164284 @default.
• W2004602458 hasConceptScore W2004602458C2779134260 @default.
• W2004602458 hasConceptScore W2004602458C2779483572 @default.
• W2004602458 hasConceptScore W2004602458C2780733421 @default.
• W2004602458 hasConceptScore W2004602458C29456083 @default.
• W2004602458 hasConceptScore W2004602458C2984863031 @default.
• W2004602458 hasConceptScore W2004602458C44249647 @default.
• W2004602458 hasConceptScore W2004602458C57089818 @default.
• W2004602458 hasConceptScore W2004602458C71924100 @default.

• next